@article{880bd7c656654ad88f932672717e0324,
title = "Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group",
abstract = "The objective of the study was to estimate the antitumor activity of pemetrexed in patients with advanced/recurrent carcinoma of the cervix and to determine the nature and degree of toxicity.",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Carcinoma, Disease-Free Survival, Female, Glutamates, Guanine, Humans, Middle Aged, Neoplasm Recurrence, Local, Uterine Cervical Neoplasms, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Carcinoma, Disease-Free Survival, Female, Glutamates, Guanine, Humans, Middle Aged, Neoplasm Recurrence, Local, Uterine Cervical Neoplasms",
author = "D Lorusso and Ferrandina, {Maria Gabriella} and S Pignata and Manuela Ludovisi and R Vigan{\`o} and S Scalone and P Scollo and E Breda and A Pietragalla and Giovanni Scambia",
year = "2010",
doi = "10.1093/annonc/mdp266",
language = "English",
volume = "21",
pages = "61--66",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",
}